Ir para o conteúdo principal

Australia Últimas notícias

Bloomberg

BlackRock's Bold AI Credit Call

BlackRock Investment Institute Global Head Jean Boivin joined Open Interest to talk about how AI is fueling the biggest investment transformation in history, making private credit one of the biggest long-term beneficiaries. He explains why investors don't need to pick AI winners to profit, why balance sheet quality matters more than ever, and why comparisons to the dot-com bubble or 2008 miss what's happening today.

Leia mais: BlackRock's Bold AI Credit Call
Bloomberg

Some Investors Rethink SpaceX Exposure

As SpaceX prepares to enter major indexes, wealth managers say clients are increasingly asking how to avoid owning the company because of Elon Musk's polarizing reputation.  Ellevest head of wealth management Emily Green joined Open Interest to discuss the  real cost of excluding stocks from index portfolios, why direct indexing is gaining traction, and what passive investors may not realize about changing index dynamics.

Leia mais: Some Investors Rethink SpaceX Exposure
Bloomberg

SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers

On this episode of Stock Movers: - Fiserv (FISV) is climbing as the Wall Street Journal reports big banks including JPMorgan Chase, Bank of America, Wells Fargo and PNC Financial Services Group have held preliminary discussions about a deal to acquire a network owned by the financial-technology company Fiserv. - Crinetics Pharmaceuticals (CRNC) is soaring after Vertex Pharmaceuticals agreed to buy Crinetics for $10 billion in cash to expand into endocrinology. - SpaceX (SPCX) is lower even though at least six brokers, including Morgan Stanley and Goldman Sachs, have started coverage of SpaceX with buy-equivalent ratings. SpaceX's addition to the Nasdaq 100 should provide considerable support to the stock, considering the number of funds that track the tech-heavy benchmark.

Leia mais: SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers
Bloomberg

Evercore's Emanuel Doesn't See Federal Reserve Moving on Rates This Year

Julian Emanuel, Evercore ISI chief equity and quantitative strategist, doesn't believe the Federal Reserve will move on interest rates this year. Emanuel is maintaining his S&P 500 year-end price target of 7,750 even though stocks have become more volatile. He speaks on "Bloomberg Surveillance."

Leia mais: Evercore's Emanuel Doesn't See Federal Reserve Moving on Rates This Year
Bloomberg

Nuveen's Cooper Sees Rotation Back Into Hyperscalers

Laura Cooper, global investment strategist and macro credit head at Nuveen, discusses the outlook for equity markets and why she sees the potential for a rotation back into hyperscalers. "Valuations have come off, we're now seeing revenue growth have a slight upturn going forward, and we've seen several weeks of consecutive outflows," Cooper tells Bloomberg Television.

Leia mais: Nuveen's Cooper Sees Rotation Back Into Hyperscalers